Literature DB >> 4347290

An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses.

J C Unkeless, A Tobia, L Ossowski, J P Quigley, D B Rifkin, E Reich.   

Abstract

Chick embryo fibroblast cultures develop fibrinolytic activity after transformation by Rous sarcoma virus (RSV). This fibrinolytic activity is not present in normal cultures, and it does not appear after infection with either nontransforming strains of avian leukosis viruses or cytocidal RNA and DNA viruses. In cultures infected with a temperature sensitive mutant of RSV the onset of fibrinolysis appears after exposure to permissive temperatures and precedes by a short interval the appearance of morphological evidence of transformation. See PDF for Structure The rate of fibrinolysis in transformed cultures depends on the nature of the serum that is present in the growth medium: some sera (e.g., monkey or chicken serum) promote high enzymatic activity, while others (calf, fetal bovine) do not. Some sera contain inhibitors of the fibrinolysin. Based on the effect of a small number of known inhibitors, at least one step of the fibrinolytic process shows specificity resembling that of trypsin. The sera of sarcoma-bearing chickens contain an inhibitor of the fibrinolysin, whereas normal chicken sera do not. For general discussion, conclusions, and summary see the accompanying paper, part II, (J. Exp. Med. 137:112).

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4347290      PMCID: PMC2139356          DOI: 10.1084/jem.137.1.85

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  133 in total

1.  Fibrinolytic activity of in vitro cultivated human bladder cell lines.

Authors:  H Hisazumi; L Andersson; V P Collins
Journal:  Urol Res       Date:  1977

2.  Synthesis of a fibrinolytic activator and inhibitor by endothelial cells.

Authors:  D J Loskutoff; T E Edgington
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

3.  Production of plasminogen activator by human and hamster cells infected with human cytomegalovirus.

Authors:  K Yamanishi; F Rapp
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

4.  Plaque assay of avian sarcoma viruses using casein.

Authors:  P C Balduzzi; H Murphy
Journal:  J Virol       Date:  1975-09       Impact factor: 5.103

5.  Hormonal regulation of plasminogen activator and peroxidase activities in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors and the rat uterus.

Authors:  K Inada; J Yamashita; T Yoshimura; S Matsuo; Y Nakashima; S Yamashita; A Misumi; M Ogawa
Journal:  Jpn J Surg       Date:  1991-03

6.  Cooperative transformation studies with temperature-sensitive mutants of Rous sarcoma virus.

Authors:  P C Balduzzi
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

Review 7.  Secretory function of mononuclear phagocytes: a review.

Authors:  E R Unanue
Journal:  Am J Pathol       Date:  1976-05       Impact factor: 4.307

8.  Hormone and neurotransmitter receptors in an established vascular endothelial cell line.

Authors:  V Buonassisi; J C Venter
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

9.  Plasminogen-independent fibrinolysis by proteases produced by transformed chick embryo fibroblasts.

Authors:  L B Chen; J M Buchanan
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

10.  Purified plasminogen activating factor produced by malignant lymphoid cells abrogates lymphocyte cytotoxicity.

Authors:  S K Sundar; J Bergeron; J Menezes
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.